GH Axis Blend
Tesamorelin + Ipamorelin
Tesa/Ipa blend
Stabilised GHRH analogue paired with the selective GHS-R agonist.
10 mg (5 + 5)20 mg (10 + 10)
Tesamorelin
Also known as: TH9507 · Egrifta · GHRH (1-44) analogue
Growth Hormone Axis In stock Box of 10 vials 1 reference
Stabilised GHRH analogue with phase 3 evidence for visceral-fat reduction.
Available sizes
| SKU | Per vial | Pack | |
|---|---|---|---|
| TSM2 | 2 mg | 10 vials / box | |
| TSM5 | 5 mg | 10 vials / box | |
| TSM10 | 10 mg | 10 vials / box | |
| TSM15 | 15 mg | 10 vials / box | |
| TSM20 | 20 mg | 10 vials / box |
Order Tesamorelin
Pricing is quoted directly and is competitive at every tier — message us with the SKUs you want and quantities for a quote.
Replies within 36 hours. Cryptocurrency (preferred) or card / money-app with a processing fee. COA for this batch available on request.
Tesamorelin is a synthetic analogue of human growth-hormone-releasing hormone (GHRH 1-44) with a trans-3-hexenoic acid group on the N-terminus that protects it from dipeptidyl-peptidase cleavage. It stimulates pulsatile, physiological GH release from the pituitary.
In a 26-week phase 3 trial in HIV-associated lipodystrophy (n = 412), tesamorelin reduced visceral adipose tissue by 15.2% versus a 5.0% increase with placebo, with corresponding increases in IGF-1 and improvements in triglycerides 1.
At a glance
- DPP-4-resistant GHRH analogue; FDA-approved reference compound
- Phase 3 visceral-fat data in NEJM
- Five sizes from 2 mg to 20 mg; also blended with ipamorelin
Research use only. All products are sold strictly for laboratory research and development purposes. They are not intended for human or veterinary use, diagnosis, treatment, cure or prevention of any disease. Not for human consumption. Summaries above describe published findings in laboratory and clinical research models and do not constitute claims about this product.
- Form
- Lyophilized powder
- Purity
- HPLC-verified — Certificate of Analysis available on request
- Pack size
- Box of 10 vials
- Storage
- Lyophilized: −20 °C, protected from light (2–8 °C short-term). Reconstituted: 2–8 °C.
- Formula
- C221H366N72O67S
- Mol. weight
- 5135.9 g/mol
- CAS No.
- 218949-48-5
Sequence, formula and CAS data are provided for identification. Batch-specific purity, mass-spec and HPLC data are on the Certificate of Analysis — ask for it with your order.
- Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-70.
Citations retrieved from PubMed (NCBI). Links open the publisher record via DOI and the PubMed abstract.
Related
Often ordered together
GH Axis
CJC-1295 (No DAC)
Modified GRF (1-29) · Mod GRF 1-29
Tetra-substituted GHRH(1-29) analogue for pulsatile GH-release research.
2 mg5 mg10 mg
GH Axis
Sermorelin Acetate
GHRH (1-29) NH2 · GRF 1-29
The native 29-residue active fragment of GHRH.
5 mg10 mg